National Heart, Lung, and Blood Institute cardiovascular clinical trial perspective

Am Heart J. 2020 Jun:224:25-34. doi: 10.1016/j.ahj.2020.02.014. Epub 2020 Feb 26.

Abstract

The National Heart, Lung, and Blood Institute (NHLBI) has played an important role in funding the clinical science that supports many contemporary cardiology practice guidelines and in shaping the conduct of cardiovascular clinical trials. This Perspective outlines contemporary funding options as well as select important NHLBI policies, philosophy, and priorities.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / therapy*
  • Clinical Trials as Topic*
  • Humans
  • National Heart, Lung, and Blood Institute (U.S.)
  • United States